Quetiapine: Efficacy and tolerability in schizophrenia

European Neuropsychopharmacology

Volumn 11, Issue SUPPL. 4, 2001, Pages

  Kasper, Siegfried ^a   Tauscher, Johannes ^a   Heiden, Angela ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atypical antipsychotic; Quetiapine; Schizophrenia; Serotonin antagonist

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN 2 RECEPTOR;

ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LONG TERM CARE; MORBIDITY; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOM;

ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; HUMANS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0034808909     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(01)00111-0     Document Type: Article

References (46)

1. Antipsychotic-induced weight gain: A comprehensive research synthesis
2. Multiple fixed doses of 'Seroquel' (Quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
3. Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial
4. Olanzapine versus haloperidol: Acute phase results of the international double-blind olanzapine trial
5. Neurocognitive impairment in schizophrenia and how it affects treatment options
6. Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimprazine in schizophrenic patients
7. ICI 204, 636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia
8. The long-term effect of quetiapine ('Seroquel') monotherapy on weight in patients with schizophrenia
9. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
10. Evaluating the effects of antipsychotics on cognition in schizophrenia
11. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204, 636, 'Seroquel') and haloperidol in schizophrenia
12. Suicide attempts associated with akathisia
13. A comparison of the effects of quetiapine ('Seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment
14. Subjective utility ratings of neuroleptics in treating schizophrenia
15. Motor and mental side effects of clozapine
16. Preclinical profile of Seroquel (quetiapine): An atypical antipsychotic with clozapine-like pharmacology
17. Low incidence of reproductive/hormonal side effects with 'Seroquel' (quetiapine fumarate) is supported by its lack of elevation of plasma prolactin concentrations
18. 'Seroquel': Efficacy in aggression, hostility and low mood schizophrenia
19. Patient satisfaction and acceptability of long-term treatment with quetiapine
20. Novel antipsychotics and extrapyramidal side effects. Theory and reality
21. New atypical antipsychotic medications
22. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
23. Review of quetiapine and its clinical applications in schizophrenia
24. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia
25. The new antipsychotics. How much better are they?
26. Patient compliance with drug therapy in schizophrenia. Economic and clinical issues
27. Treatment of schizophrenia
28. Risperidone in the treatment of schizophrenia
29. Extrapyramidal side effects and tolerability of risperidone: A review
30. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia
31. Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol
32. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol
33. Maintenance of long-term efficacy with 'Seroquel' (quetiapine)
34. Maintenance of long-term efficacy with 'Seroquel'
35. Quetiapine and risperidone in outpatients with psychotic disorders: Results of the QUEST trial
36. Conventional versus novel antipsychotics: Changing concepts and clinical implications
37. Seroquel: Biochemical profile of a potential atypical antipsychotic
38. Attentional improvement following quetiapine fumarate treatment in schizophrenia
39. Efficacy of quetiapine vs. haloperidol and placebo in the short-term treatment of acute schizophrenia
40. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo
41. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol
42. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
43. Akathisia with haloperidol and thiothixene
44. Changes in cognitive functioning with quetiapine fumarate versus haloperidol
45. Atypical antipsychotic agents: A critical review